Ad is loading...
FNRCX
Price
$42.68
Change
-$0.35 (-0.81%)
Updated
Nov 15 closing price
FSENX
Price
$61.31
Change
-$0.51 (-0.82%)
Updated
Nov 15 closing price
Ad is loading...

FNRCX vs FSENX

Header iconFNRCX vs FSENX Comparison
Open Charts FNRCX vs FSENXBanner chart's image
Fidelity Advisor Energy C
Price$42.68
Change-$0.35 (-0.81%)
VolumeN/A
CapitalizationN/A
Fidelity Select Energy Portfolio
Price$61.31
Change-$0.51 (-0.82%)
VolumeN/A
CapitalizationN/A
FNRCX vs FSENX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNRCX vs. FSENX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNRCX is a Buy and FSENX is a Buy.

FUNDAMENTALS
Fundamentals
FSENX has more cash in the bank: 2B vs. FNRCX (1.17B). FSENX pays higher dividends than FNRCX: FSENX (1.72) vs FNRCX (1.23). FNRCX was incepted earlier than FSENX: FNRCX (27 years) vs FSENX (43 years). FSENX is a more actively managed with annual turnover of: 43.00 vs. FNRCX (21.00). FNRCX (0) and FSENX (0) have matching initial minimum investment requirements. FSENX annual gain was more profitable for investors over the last year : 11.14 vs. FNRCX (9.85). FSENX return over 5 years is better than : 95.98 vs. FNRCX (86.86).
FNRCXFSENXFNRCX / FSENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years43 years-
Gain YTD9.38010.49789%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.17B2B58%
Annual Yield % from dividends1.231.7271%
Returns for 1 year9.8511.1488%
Returns for 3 years68.4974.4792%
Returns for 5 years86.8695.9890%
Returns for 10 years29.9731.8994%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOVX1.360.01
+0.74%
Theriva Biologics Inc
HBNC18.27-0.20
-1.08%
Horizon Bancorp
PJT157.32-1.94
-1.22%
PJT Partners
ATR166.49-7.61
-4.37%
AptarGroup
LPTX2.74-0.15
-5.19%
Leap Therapeutics